“We’ve opened pandora’s box, haven’t we?” clinical geneticists’ views on ethical aspects of genomic testing in neonatal intensive care

1National Human Genome Research Institute. Fact sheet: The cost of sequencing a human genome. 2019 September 2019]; Available from: https://www.genome.gov/about-genomics/fact-sheets/Sequencing-Human-Genome-costNational Human Genome Research Institute Fact sheet: The cost of sequencing a human genome 2019 September 2019]; Available from https://www.genome.gov/about-genomics/fact-sheets/Sequencing-Human-Genome-costSearch in Google Scholar

2van Nimwegen, K.J., et al., Is the $1000 genome as near as we think? A cost analysis of next-generation sequencing. Clin Chem, 2016. 62(11): p. 1458-1464.van Nimwegen K.J. et al Is the $1000 genome as near as we think? A cost analysis of next-generation sequencing Clin Chem 2016 6211 1458 146410.1373/clinchem.2016.25863227630156Search in Google Scholar

3Retterer, K., et al., Clinical application of wholeexome sequencing across clinical indications. Genet Med, 2016. 18(7): p. 696-704.Retterer K. et al Clinical application of wholeexome sequencing across clinical indications Genet Med 2016 187 696 70410.1038/gim.2015.14826633542Search in Google Scholar

4Wright, C.F., D.R. FitzPatrick, and H.V. Firth, Paediatric genomics: diagnosing rare disease in children. Nat Rev Genet, 2018. 19(5): p. 253-268.Wright C.F. FitzPatrick D.R. Firth H.V. Paediatric genomics: diagnosing rare disease in children Nat Rev Genet 2018 195 253 26810.1038/nrg.2017.11629398702Search in Google Scholar

5Lionel, A.C., et al., Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test. Genet Med, 2018. 20(4): p. 435-443.Lionel A.C. et al Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test Genet Med 2018 204 435 44310.1038/gim.2017.119589546028771251Search in Google Scholar

6Meng, L., et al., Use of exome sequencing for infants in intensive care units: Ascertainment of severe single-gene disorders and effect on medical management. JAMA Pediatr, 2017. 171(12): p. e173438.Meng L. et al Use of exome sequencing for infants in intensive care units: Ascertainment of severe single-gene disorders and effect on medical management JAMA Pediatr 2017 17112 e17343810.1001/jamapediatrics.2017.3438635992728973083Search in Google Scholar

7Willig, L.K., et al., Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings. Lancet Respir Med, 2015. 3(5): p. 377-387.Willig L.K. et al Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings Lancet Respir Med 2015 35 377 38710.1016/S2213-2600(15)00139-3447919425937001Search in Google Scholar

8Elliott, A.M., et al., RAPIDOMICS: rapid genomewide sequencing in a neonatal intensive care unit-successes and challenges. Eur J Pediatr, 2019. 178(8): p. 1207-1218.Elliott A.M. et al RAPIDOMICS: rapid genomewide sequencing in a neonatal intensive care unit-successes and challenges Eur J Pediatr 2019 1788 1207 121810.1007/s00431-019-03399-431172278Search in Google Scholar

9Gubbels, C.S., et al., Prospective, phenotype-driven selection of critically ill neonates for rapid exome sequencing is associated with high diagnostic yield. Genet Med, 2019.Gubbels C.S. et al Prospective, phenotype-driven selection of critically ill neonates for rapid exome sequencing is associated with high diagnostic yield Genet Med 201910.1038/s41436-019-0708-6712796831780822Search in Google Scholar

10van der Sluijs, P.J., et al., Putting genome-wide sequencing in neonates into perspective. Genet Med, 2019. 21(5): p. 1074-1082.van der Sluijs P.J. et al Putting genome-wide sequencing in neonates into perspective Genet Med 2019 215 1074 108210.1038/s41436-018-0293-030287924Search in Google Scholar

11Miller, N.A., et al., A 26-hour system of highly sensitive whole genome sequencing for emergency management of genetic diseases. Genome Med, 2015. 7: p. 100.Miller N.A. et al A 26-hour system of highly sensitive whole genome sequencing for emergency management of genetic diseases Genome Med 2015 7 10010.1186/s13073-015-0221-8458825126419432Search in Google Scholar

12Farnaes, L., et al., Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization. NPJ Genom Med, 2018. 3: p. 10.Farnaes L. et al Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization NPJ Genom Med 2018 3 1010.1038/s41525-018-0049-4588482329644095Search in Google Scholar

13Stark, Z., et al., Meeting the challenges of implementing rapid genomic testing in acute pediatric care. Genet Med, 2018. 20: p. 1554-1563.Stark Z. et al Meeting the challenges of implementing rapid genomic testing in acute pediatric care Genet Med 2018 20 1554 156310.1038/gim.2018.3729543227Search in Google Scholar

14Stark, Z., et al., Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement. Genet Med, 2017. 19(8): p. 867-874.Stark Z. et al Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement Genet Med 2017 198 867 87410.1038/gim.2016.22128125081Search in Google Scholar

15Stark, Z., et al., Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness. Genet Med, 2019. 21: p. 173-180.Stark Z. et al Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness Genet Med 2019 21 173 18010.1038/s41436-018-0006-829765138Search in Google Scholar

16Amendola, L.M., et al., Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. Am J Hum Genet, 2016. 98(6): p. 1067-1076.Amendola L.M. et al Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium Am J Hum Genet 2016 986 1067 107610.1016/j.ajhg.2016.03.024490818527181684Search in Google Scholar

17Bland, A., et al., Clinically impactful differences in variant interpretation between clinicians and testing laboratories: a single-center experience. Genet Med, 2018. 20(3): p. 369-373.Bland A. et al Clinically impactful differences in variant interpretation between clinicians and testing laboratories: a single-center experience Genet Med 2018 203 369 37310.1038/gim.2017.21229240077Search in Google Scholar

18American Academy of Pediatrics and American College of Medical Genetics, Ethical and policy issues in genetic testing and screening of children. Pediatrics, 2013. 131(3): p. 620-622.American Academy of Pediatrics and American College of Medical Genetics, Ethical and policy issues in genetic testing and screening of children Pediatrics 2013 1313 620 62210.1542/peds.2012-368023428972Search in Google Scholar

19Botkin, J.R., et al., Points to consider: Ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet, 2015. 97(1): p. 6-21.Botkin J.R. et al Points to consider: Ethical, legal, and psychosocial implications of genetic testing in children and adolescents Am J Hum Genet 2015 971 6 2110.1016/j.ajhg.2015.05.022457099926140447Search in Google Scholar

20Newson, A.J. and L. Schonstein, Genomic testing in the paediatric population: Ethical considerations in light of recent policy statements. Mol Diagn Ther, 2016. 20(5): p. 407-14.Newson A.J. Schonstein L. Genomic testing in the paediatric population: Ethical considerations in light of recent policy statements Mol Diagn Ther 2016 205 407 1410.1007/s40291-016-0210-727251403Search in Google Scholar

21Ross, L.F., et al., Technical report: Ethical and policy issues in genetic testing and screening of children. Genet Med, 2013. 15(3): p. 234-245.Ross L.F. et al Technical report: Ethical and policy issues in genetic testing and screening of children Genet Med 2013 153 234 24510.1038/gim.2012.17623429433Search in Google Scholar

22Deem, M.J., Whole-genome sequencing and disability in the NICU: Exploring practical and ethical challenges. Pediatrics, 2016. 137 Suppl 1: p. S47-55.Deem M.J. Whole-genome sequencing and disability in the NICU: Exploring practical and ethical challenges Pediatrics 2016 137 Suppl 1 S47 5510.1542/peds.2015-3731I992397326729703Search in Google Scholar

23Gyngell, C., et al., Rapid challenges: ethics and genomics in neonatal intensive care. Paediatrics, 2019. 143(Suppl 1): p. S14-21.Gyngell C. et al Rapid challenges: ethics and genomics in neonatal intensive care Paediatrics 2019 143Suppl 1 S14 2110.1542/peds.2018-1099D637905730600266Search in Google Scholar

24Wilkinson, D.J., et al., Genomic intensive care: should we perform genome testing in critically ill newborns? Arch Dis Child Fetal Neonatal Ed, 2016. 101(2): p. F94-98.Wilkinson D.J. et al Genomic intensive care: should we perform genome testing in critically ill newborns? Arch Dis Child Fetal Neonatal Ed 2016 1012 F94 9810.1136/archdischild-2015-308568478971426369368Search in Google Scholar

25Frankel, L.A., S. Pereira, and A.L. McGuire, Potential psychosocial risks of sequencing newborns. Pediatrics, 2016. 137 Suppl 1: p. S24-29.Frankel L.A. Pereira S. McGuire A.L. Potential psychosocial risks of sequencing newborns Pediatrics 2016 137 Suppl 1: p S24 2910.1542/peds.2015-3731F992397126729699Search in Google Scholar

26Szego, M.J., et al., Views from the clinic: Healthcare provider perspectives on whole genome sequencing in paediatrics. Eur J Med Genet, 2019. 62(5): p. 350-356.Szego M.J. et al Views from the clinic: Healthcare provider perspectives on whole genome sequencing in paediatrics Eur J Med Genet 2019 625 350 35610.1016/j.ejmg.2018.11.02930503855Search in Google Scholar

27Knapp, B., C. Decker, and J.D. Lantos, Neonatologists’ attitudes about diagnostic whole-genome sequencing in the NICU. Pediatrics, 2019. 143(Suppl 1): p. S54-S57.Knapp B. Decker C. Lantos J.D. Neonatologists’ attitudes about diagnostic whole-genome sequencing in the NICU Pediatrics 2019 143Suppl 1 S54 S5710.1542/peds.2018-1099J30600272Search in Google Scholar

28Stark, Z., et al., Attitudes of Australian health professionals towards rapid genomic testing in neonatal and paediatric intensive care. Eur J Hum Genet, 2019. 27(10): p. 1493-1501.Stark Z. et al Attitudes of Australian health professionals towards rapid genomic testing in neonatal and paediatric intensive care Eur J Hum Genet 2019 2710 1493 150110.1038/s41431-019-0429-y677745731148592Search in Google Scholar

29Braun, V. and V. Clarke, Using thematic analysis in psychology. Qual Res Psychol, 2006. 3(2): p. 77-101.Braun V. Clarke V. Using thematic analysis in psychology Qual Res Psychol 2006 32 77 10110.1191/1478088706qp063oaSearch in Google Scholar

30Mays, N. and C. Pope, Rigour and qualitative research. BMJ, 1995. 311(6997): p. 109-112.Mays N. Pope C. Rigour and qualitative research BMJ 1995 3116997 109 11210.1136/bmj.311.6997.10925501547613363Search in Google Scholar

31Mays, N. and C. Pope, Qualitative research in health care. Assessing quality in qualitative research. BMJ, 2000. 320(7226): p. 50-52.Mays N. Pope C. Qualitative research in health care. Assessing quality in qualitative research BMJ 2000 3207226 50 5210.1136/bmj.320.7226.50111732110617534Search in Google Scholar

32Morley, G., et al., What is ‘moral distress’? A narrative synthesis of the literature. Nurs Ethics, 2019. 26(3): p. 646-662.Morley G. et al What is ‘moral distress’? A narrative synthesis of the literature Nurs Ethics 2019 263 646 66210.1177/0969733017724354650690328990446Search in Google Scholar

33Dive, L. and A.J. Newson, Reconceptualizing Autonomy for Bioethics. Kennedy Inst Ethics J, 2018. 28(2): p. 171-203.Dive L. Newson A.J. Reconceptualizing Autonomy for Bioethics Kennedy Inst Ethics J 2018 282 171 20310.1353/ken.2018.001330100599Search in Google Scholar

34Burke, K. and A. Clarke, The challenge of consent in clinical genome-wide testing. Arch Dis Child, 2016. 101(11): p. 1048-1052.Burke K. Clarke A. The challenge of consent in clinical genome-wide testing Arch Dis Child 2016 10111 1048 105210.1136/archdischild-2013-30410927127186Search in Google Scholar